“Trump’s pharmaceutical policies have too many uncertain aspects and will not bring immediate impacts”

President-elect Donald Trump’s policies may bring positive impacts on Korean biosimilars’ entry to overseas markets, but an anticipation was made that it will not significantly influence the pharmaceutical market, yet.

At the ‘Political and Legislative Countermeasures for Biotechnology and Pharmaceutical Fields on Changes in International Situation’ jointly hosted by People’s Party Rep. Do-Ja ...